JP2005504814A5 - - Google Patents

Download PDF

Info

Publication number
JP2005504814A5
JP2005504814A5 JP2003531978A JP2003531978A JP2005504814A5 JP 2005504814 A5 JP2005504814 A5 JP 2005504814A5 JP 2003531978 A JP2003531978 A JP 2003531978A JP 2003531978 A JP2003531978 A JP 2003531978A JP 2005504814 A5 JP2005504814 A5 JP 2005504814A5
Authority
JP
Japan
Prior art keywords
tumor
perfusion
identified
individual
choriocarcinoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003531978A
Other languages
English (en)
Japanese (ja)
Other versions
JP5280603B2 (ja
JP2005504814A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/031079 external-priority patent/WO2003028642A2/en
Publication of JP2005504814A publication Critical patent/JP2005504814A/ja
Publication of JP2005504814A5 publication Critical patent/JP2005504814A5/ja
Application granted granted Critical
Publication of JP5280603B2 publication Critical patent/JP5280603B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003531978A 2001-10-01 2002-10-01 転移阻害のための方法 Expired - Fee Related JP5280603B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32628801P 2001-10-01 2001-10-01
US60/326,288 2001-10-01
PCT/US2002/031079 WO2003028642A2 (en) 2001-10-01 2002-10-01 Methods of inhibiting metastases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010107880A Division JP2010209101A (ja) 2001-10-01 2010-05-10 転移阻害のための方法

Publications (3)

Publication Number Publication Date
JP2005504814A JP2005504814A (ja) 2005-02-17
JP2005504814A5 true JP2005504814A5 (enExample) 2006-01-05
JP5280603B2 JP5280603B2 (ja) 2013-09-04

Family

ID=23271590

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003531978A Expired - Fee Related JP5280603B2 (ja) 2001-10-01 2002-10-01 転移阻害のための方法
JP2010107880A Pending JP2010209101A (ja) 2001-10-01 2010-05-10 転移阻害のための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010107880A Pending JP2010209101A (ja) 2001-10-01 2010-05-10 転移阻害のための方法

Country Status (6)

Country Link
US (2) US6753328B2 (enExample)
EP (1) EP1450814B1 (enExample)
JP (2) JP5280603B2 (enExample)
AU (1) AU2002362459B2 (enExample)
CA (1) CA2462564C (enExample)
WO (1) WO2003028642A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003028642A2 (en) * 2001-10-01 2003-04-10 Rhode Island Hospital, A Lifespan Partner Methods of inhibiting metastases
CA2820537C (en) 2003-04-23 2015-10-20 Valeritas, Inc. Hydraulically actuated pump for fluid administration
US9089636B2 (en) 2004-07-02 2015-07-28 Valeritas, Inc. Methods and devices for delivering GLP-1 and uses thereof
ES2656675T3 (es) 2006-03-30 2018-02-28 Valeritas, Inc. Dispositivo de suministro de fluidos de múltiples cartuchos
RU2468796C2 (ru) * 2006-09-07 2012-12-10 Эд. Гайстлих Зёне Аг Фюр Хемише Индустри Способ лечения рака костей
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
ES2711504T3 (es) 2009-07-24 2019-05-06 Rhode Island Hospital Vacunas de células dendríticas para tumores que expresan asparaginil-beta-hidroxilasa
US11738120B1 (en) 2022-04-14 2023-08-29 Cormedix Inc. Synthesis of taurolidine, purity profiles and polymorphs

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1124285A (en) 1964-10-06 1968-08-21 Geistlich Soehne Ag Novel perhydro-1,2,4-thiadiazine dioxides-(1,1), their preparation and compositionscontaining them
GB1408010A (en) 1972-11-20 1975-10-01 Geistlich Soehne Ag Sulphamoylphenyl-imidazolidinones
GB1557163A (en) 1975-06-24 1979-12-05 Geistlich Soehne Ag Dental care preparations
US4107305A (en) 1975-08-04 1978-08-15 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Treatment of endotoxaemia
GB1588110A (en) 1978-05-31 1981-04-15 Geistlich Soehne Ag Pharmaceutical compositions for the treatment of scars
US4337251A (en) 1979-05-09 1982-06-29 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of avoiding and removing adhesions
CA1190855A (en) 1980-09-03 1985-07-23 Rolf W. Pfirrmann Treatment of osteitis
GB8328074D0 (en) 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compositions
GB8328073D0 (en) 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compounds
GB8328111D0 (en) 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compounds
US5210083A (en) 1986-07-17 1993-05-11 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Pharmaceutical compositions
GB8617482D0 (en) 1986-07-17 1986-08-28 Geistlich Soehne Ag Pharmaceutical composition
US5573771A (en) 1988-08-19 1996-11-12 Osteomedical Limited Medicinal bone mineral products
US5069662A (en) * 1988-10-21 1991-12-03 Delcath Systems, Inc. Cancer treatment
US5819748A (en) 1988-11-30 1998-10-13 Ed Geistlich Sohne Ag Fur Chemische Industrie Implant for use in bone surgery
GB8827986D0 (en) 1988-11-30 1989-01-05 Geistlich Soehne Ag Chemical product
GB9005856D0 (en) 1990-03-15 1990-05-09 Geistlich Soehne Ag Compositions
GB9015108D0 (en) 1990-07-09 1990-08-29 Geistlich Soehne Ag Chemical compositions
US5635532A (en) 1991-10-21 1997-06-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
GB9216155D0 (en) 1992-07-30 1992-09-09 Geistlich Soehne Ag Treatment of dentoalveolar infections
US5954687A (en) 1995-04-28 1999-09-21 Medtronic, Inc. Burr hole ring with catheter for use as an injection port
US5976822A (en) 1995-05-18 1999-11-02 Coulter International Corp. Method and reagent for monitoring apoptosis and distinguishing apoptosis from necrosis
GB9600426D0 (en) 1996-01-10 1996-03-13 Ed Geistlich Sohne A G Compositions
US6303596B1 (en) 1997-05-22 2001-10-16 Oklahoma Medical Research Foundation Use of taurolidine for treatment of leukemias
US6479481B1 (en) 1999-06-04 2002-11-12 Ed. Geistlich Soehne Ag Fur Chemische Industrie Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)
US7151099B2 (en) * 1998-07-31 2006-12-19 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Use of taurolidine and/or taurultam for treatment of abdominal cancer and/or for the prevention of metastases
GB9716219D0 (en) * 1997-07-31 1997-10-08 Geistlich Soehne Ag Prevention of metastases
US6011030A (en) 1997-09-22 2000-01-04 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of treating symptoms of microbial infection or sepsis
US5972933A (en) 1998-01-08 1999-10-26 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of treating microbial infections
US6117868A (en) 1998-09-16 2000-09-12 Ed. Geistlich Sohne Ag Fur Chemische Industrie Treatment of gastrointestinal ulcers or gastritis caused by microbial infection
SE516215C2 (sv) * 1999-07-10 2001-12-03 Argmed Kb Perfusionssystem samt pumpanordning och styrsystem för användning i perfusionssystemet
EP1246617B1 (en) * 1999-12-06 2006-09-13 Rhode Island Hospital Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of ovarian cancer
AU779362B2 (en) * 2000-10-27 2005-01-20 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of tumor metastases and cancer
CA2363973C (en) * 2000-11-28 2009-03-10 Ed. Geistlich Sohne Ag Fur Chemische Industrie Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
WO2003028642A2 (en) * 2001-10-01 2003-04-10 Rhode Island Hospital, A Lifespan Partner Methods of inhibiting metastases

Similar Documents

Publication Publication Date Title
AU2003222103A1 (en) Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomas
NO20043345L (no) Fremgangsmate for fremstilling av hydrokarboner
IS7095A (is) Arýlamín til meðhöndlunar á ástandi sem tengist GSK-3
FI20030967A0 (fi) Yhteysasetusten valinta
JP2010504908A5 (enExample)
AU2003268052A8 (en) Production of purified water and high value chemicals from salt water
NO20053860D0 (no) COP 1 for behandling av inflammatorisk tarmsykdom.
CY1108808T1 (el) Ενωσεις μοτιλιδης
JP2005504814A5 (enExample)
EP1671998A3 (en) Process to form compound with indolocarbazole moieties
AP2006003593A0 (en) Production of Titania.
NZ597857A (en) Method and composition for treating mucosal disorders
ATE399175T1 (de) Hemmstoffe der urokinase, ihre herstellung und verwendung
DE602004023786D1 (de) Herstellung von hochreinem Alkylgallium
DE602004026174D1 (de) Produktion von minicircle-vektoren
IS7569A (is) 1-asa-díbensóasúlen sem latar æxlisdrepþáttar framleiðslu og milliefni til framleiðslu á þeim
IS7568A (is) 1,3-díasa-díbensóasúlen sem latar æxlisdrepþáttarframleiðslu og milliefni til framleiðslu á þeim
SE0950616L (sv) Flerstegsframställning av mekanisk massa med AP genom blåslinjebehandling med raffinör
JP2008514710A5 (enExample)
EP1645664A4 (de) Verfahren zur herstellung von fancy-red-diamanten
ATE301127T1 (de) Ferrocenylliganden und ein verfahren zur herstellung solcher liganden
DE60302455D1 (de) Genussfähige emulsion mit lebenden mikroorganismen
ZA200703482B (en) B7-H1 and methods of diagnosis, prognosis, and treatment of cancer
IS7565A (is) 1,2-díasa-díbensóasúlen sem latar æxlisdrepþáttarframleiðslu og milliefni til framleiðslu á þeim
JP2006522596A5 (enExample)